China’s AI drug-discovery champion sees survival as the biggest challenge
By Chen Guangjing Do China’s AI drug discovery champions need to worry about survival? For Wen…
Eli Lilly bets $2.75 billion on Insilico Medicine: is this AI drug discovery’s ‘GPT moment’?
By Hualin Wuwang Another traditional industry has officially fallen for AI. On March 29, US pharmaceutical…
Biotech startup METiS Therapeutics plans Hong Kong IPO with AI-driven drug delivery revolution
By Da Cheung METiS Therapeutics, a drug discovery and delivery biotech, has received the regulatory green light…
Meinian Health, Ant Health forge strategic partnership to build a new model for AI-era healthcare services
By Su Da In China’s vast healthcare system, medical check-ups serve as the first “valve,” a…
China’s Wallaby Phenox secures funding, merges with Enlight Medical amid pivot to brain-computer interfaces
By Da Cheung Chinese neurovascular medical device maker Wallaby Phenox completed a new equity financing and debt restructuring…
Latest
- ByteDance revamps Seed team structure as it prepares for larger AI models
- Alibaba bets $10.2 billion on AI infrastructure in Hong Kong share sale
- Yangtze Memory IPO: A blockbuster quarter, but three hurdles loom
- InnoLight rides AI infrastructure boom as China spending lags
- Spacecom raises $1 billion in record funding round to build out satellite constellation
